Download
s00345-020-03154-7.pdf 729,20KB
WeightNameValue
1000 Titel
  • Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial
1000 Autor/in
  1. Albers, Peter |
  2. Wiegel, Thomas |
  3. Schmidberger, Heinz |
  4. Bussar-Maatz, Roswitha |
  5. Härter, Martin |
  6. Kristiansen, Glen |
  7. Martus, Peter |
  8. Meisner, Christoph |
  9. Wellek, Stefan |
  10. Grozinger, Klaus |
  11. Renner, Peter |
  12. Burmester, Martin |
  13. Schneider, Fried |
  14. Stöckle, Michael |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-03-18
1000 Erschienen in
1000 Quellenangabe
  • 39(1):65-72
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00345-020-03154-7 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858200/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!Active surveillance (AS) strategies for patients with low- and early intermediate-risk prostate cancer are still not consistently defined. Within a controlled randomized trial, active surveillance was compared to other treatment options for patients with prostate cancer. Aim of this analysis was to report on termination rates of patients treated with AS including different grade groups.!##!Methods!#!A randomized trial comparing radical prostatectomy, active surveillance, external beam radiotherapy and brachytherapy was performed from 2013 to 2016 and included 345 patients with low- and early intermediate-risk prostate cancer (ISUP grade groups 1 and 2). The trial was prematurely stopped due to slow accrual. A total of 130 patients were treated with active surveillance. Among them, 42 patients were diagnosed with intermediate-risk PCA. Reference pathology and AS quality control were performed throughout.!##!Results!#!After a median follow-up time of 18.8 months, 73 out of the 130 patients (56%) terminated active surveillance. Of these, 56 (77%) patients were histologically reclassified at the time of rebiopsy, including 35% and 60% of the grade group 1 and 2 patients, respectively. No patients who underwent radical prostatectomy at the time of reclassification had radical prostatectomy specimens ≥ grade group 3.!##!Conclusion!#!In this prospectively analyzed subcohort of patients with AS and conventional staging within a randomized trial, the 2-year histological reclassification rates were higher than those previously reported. Active surveillance may not be based on conventional staging alone, and patients with grade group 2 cancers may be recommended for active surveillance in carefully controlled trials only.
1000 Sacherschließung
lokal Adolescent [MeSH]
lokal Watchful Waiting [MeSH]
lokal Reclassification
lokal Aged [MeSH]
lokal Risk Assessment [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Active surveillance
lokal Prostatic Neoplasms/pathology [MeSH]
lokal Middle Aged [MeSH]
lokal Time Factors [MeSH]
lokal Original Article
lokal Early Termination of Clinical Trials/statistics
lokal Male [MeSH]
lokal Young Adult [MeSH]
lokal Clinical trial
lokal Prostatic Neoplasms/therapy [MeSH]
lokal Prostatic Neoplasms/classification [MeSH]
lokal Prostate cancer
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-1747-9615|https://frl.publisso.de/adhoc/uri/V2llZ2VsLCBUaG9tYXM=|https://frl.publisso.de/adhoc/uri/U2NobWlkYmVyZ2VyLCBIZWlueg==|https://frl.publisso.de/adhoc/uri/QnVzc2FyLU1hYXR6LCBSb3N3aXRoYQ==|https://frl.publisso.de/adhoc/uri/SMOkcnRlciwgTWFydGlu|https://frl.publisso.de/adhoc/uri/S3Jpc3RpYW5zZW4sIEdsZW4=|https://frl.publisso.de/adhoc/uri/TWFydHVzLCBQZXRlcg==|https://frl.publisso.de/adhoc/uri/TWVpc25lciwgQ2hyaXN0b3Bo|https://frl.publisso.de/adhoc/uri/V2VsbGVrLCBTdGVmYW4=|https://frl.publisso.de/adhoc/uri/R3JvemluZ2VyLCBLbGF1cw==|https://frl.publisso.de/adhoc/uri/UmVubmVyLCBQZXRlcg==|https://frl.publisso.de/adhoc/uri/QnVybWVzdGVyLCBNYXJ0aW4=|https://frl.publisso.de/adhoc/uri/U2NobmVpZGVyLCBGcmllZA==|https://frl.publisso.de/adhoc/uri/U3TDtmNrbGUsIE1pY2hhZWw=
1000 Hinweis
  • DeepGreen-ID: 04530583081d4ccc8d2f8bd1ea401091 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6466836.rdf
1000 Erstellt am 2023-11-17T03:39:41.492+0100
1000 Erstellt von 322
1000 beschreibt frl:6466836
1000 Zuletzt bearbeitet 2023-12-01T04:56:37.904+0100
1000 Objekt bearb. Fri Dec 01 04:56:37 CET 2023
1000 Vgl. frl:6466836
1000 Oai Id
  1. oai:frl.publisso.de:frl:6466836 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source